|
|
|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Artiva Biotherapeutics, Inc. (ARTV) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
24,295,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
13,749,996 |
| Total Buy Value |
$0 |
$0 |
$0 |
$164,999,952 |
| Total People Bought |
0 |
0 |
0 |
5 |
| Total Buy Transactions |
0 |
0 |
0 |
6 |
| Total Shares Sold |
31,875 |
57,375 |
57,375 |
57,375 |
| Total Sell Value |
$174,522 |
$244,101 |
$244,101 |
$244,101 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
2 |
3 |
3 |
3 |
| End Date |
2025-08-21 |
2025-05-20 |
2024-11-19 |
2023-11-20 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
Aslan Fred |
President and CEO |
|
2025-11-17 |
4 |
AS |
$3.38 |
$21,522 |
D/D |
(6,375) |
343,999 |
|
- |
|
Raymon Heather |
SVP, Research and Development |
|
2025-11-15 |
4 |
D |
$3.25 |
$4,469 |
D/D |
(1,375) |
39,591 |
|
- |
|
Aslan Fred |
President and CEO |
|
2025-11-15 |
4 |
D |
$3.25 |
$20,628 |
D/D |
(6,347) |
350,374 |
|
- |
|
Bush Jennifer |
COO, CLO, Secy, Compliance Off |
|
2025-11-15 |
4 |
D |
$3.25 |
$9,929 |
D/D |
(3,055) |
148,048 |
|
- |
|
Horan Christopher |
Chief Tech Operations Officer |
|
2025-11-15 |
4 |
D |
$3.25 |
$6,172 |
D/D |
(1,899) |
78,183 |
|
- |
|
Krishnamohan Neha |
Chief Financial Officer |
|
2025-11-15 |
4 |
D |
$3.25 |
$11,343 |
D/D |
(3,490) |
99,356 |
|
- |
|
Aslan Fred |
President and CEO |
|
2025-10-17 |
4 |
AS |
$6.00 |
$153,000 |
D/D |
(25,500) |
356,721 |
|
- |
|
Aslan Fred |
President and CEO |
|
2025-08-15 |
4 |
D |
$2.75 |
$12,298 |
D/D |
(4,472) |
382,221 |
|
- |
|
Aslan Fred |
President and CEO |
|
2025-08-15 |
4 |
AS |
$2.73 |
$69,579 |
D/D |
(25,500) |
386,693 |
|
- |
|
Bush Jennifer |
COO, CLO, Secy, Compliance Off |
|
2025-08-15 |
4 |
D |
$2.75 |
$17,625 |
D/D |
(6,409) |
151,103 |
|
- |
|
Horan Christopher |
Chief Tech Operations Officer |
|
2025-08-15 |
4 |
D |
$2.75 |
$9,837 |
D/D |
(3,577) |
80,082 |
|
- |
|
Raymon Heather |
SVP, Research and Development |
|
2025-08-15 |
4 |
D |
$2.75 |
$4,507 |
D/D |
(1,639) |
40,966 |
|
- |
|
Krishnamohan Neha |
Chief Financial Officer |
|
2025-08-15 |
4 |
D |
$2.75 |
$15,986 |
D/D |
(5,813) |
102,846 |
|
- |
|
Aslan Fred |
President and CEO |
|
2025-05-15 |
4 |
D |
$2.13 |
$9,525 |
D/D |
(4,472) |
412,193 |
|
- |
|
Bush Jennifer |
COO, CLO, Secy, Compliance Off |
|
2025-05-15 |
4 |
D |
$2.13 |
$4,126 |
D/D |
(1,937) |
157,512 |
|
- |
|
Horan Christopher |
Chief Tech Operations Officer |
|
2025-05-15 |
4 |
D |
$2.13 |
$2,856 |
D/D |
(1,341) |
83,659 |
|
- |
|
Raymon Heather |
SVP, Research and Development |
|
2025-05-15 |
4 |
D |
$2.13 |
$1,587 |
D/D |
(745) |
42,605 |
|
- |
|
Krishnamohan Neha |
Chief Financial Officer |
|
2025-05-15 |
4 |
D |
$2.13 |
$2,856 |
D/D |
(1,341) |
108,659 |
|
- |
|
Banerjee Subhashis |
Chief Medical Officer |
|
2025-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
Aslan Fred |
President and CEO |
|
2025-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
416,665 |
|
- |
|
Horan Christopher |
Chief Tech Operations Officer |
|
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
85,000 |
|
- |
|
Krishnamohan Neha |
Chief Financial Officer |
|
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
110,000 |
|
- |
|
Bush Jennifer |
COO, CLO, Secy, Compliance Off |
|
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
86,650 |
159,449 |
|
- |
|
Raymon Heather |
SVP, Research and Development |
|
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
33,350 |
43,350 |
|
- |
|
Graef Thorsten |
Chief Medical Officer |
|
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
80,000 |
|
- |
|
55 Records found
|
|
Page 1 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|